[HTML][HTML] Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

…, M Smith, Y Ganga, Z Jule, K Reedoy, SH Hwa… - Nature, 2022 - nature.com
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …

[HTML][HTML] Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant

…, M Groenewald, E Horne, SH Hwa… - … England Journal of …, 2021 - Mass Medical Soc
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …

[HTML][HTML] Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma

S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig… - Nature, 2021 - nature.com
SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations 1 ,
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…

[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection

…, M Smith, Y Ganga, Z Jule, K Reedoy, SH Hwa… - MedRxiv, 2021 - ncbi.nlm.nih.gov
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …

[PDF][PDF] SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape

…, E Wilkinson, M Bernstein, K Khan, SH Hwa… - Cell host & …, 2022 - cell.com
Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …

[HTML][HTML] SARS-CoV-2 Omicron variant emerged under immune selection

…, F Zhu, BE Young, N Chantasrisawad, SH Hwa… - Nature …, 2022 - nature.com
The SARS-CoV-2 Omicron variant (B.1.1.529 lineage) escapes antibodies that neutralize
the ancestral virus. We tested human serum panels from participants with differing infection …

Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B. 1.351 variant in South Africa

…, J Plessis, A Esmail, M Groenewald, E Horne, SH Hwa… - MedRxiv, 2021 - medrxiv.org
Background Assessing safety and efficacy of Covid-19 vaccines in different populations is
essential, as is investigation of efficacy against emerging SARS-CoV-2 variants of concern …

HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway

R Krause, J Snyman, H Shi-Hsia, D Muema, F Karim… - Elife, 2022 - elifesciences.org
Background: HIV infection dysregulates the B cell compartment, affecting memory B cell
formation and the antibody response to infection and vaccination. Understanding the B cell …

Similar antibody responses against severe acute respiratory syndrome coronavirus 2 in individuals living without and with human immunodeficiency virus on …

J Snyman, SH Hwa, R Krause, D Muema… - Clinical Infectious …, 2022 - academic.oup.com
Background There is limited understanding of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) pathogenesis in African populations with a high burden of infectious …

[PDF][PDF] Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave

J Snyman, SH Hwa, R Krause, D Muema… - Clinical Infectious …, 2021 - pure.mpg.de
Background. There is limited understanding of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) pathogenesis in African populations with a high burden of infectious …